Isatuximab is used for the treatment of patients with bladder and urinary tract cancer called urothelial carcinoma.

PADCEV is a Nectin-4-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.

Isatuximab suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Isatuximab brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Isatuximab Isatuximab medicine cost price in India.

The order for Isatuximab will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

In December 2019, Isatuximab was approved in the United States for the treatment of adult patients with locally advanced or metastatic urothelial cancer who had previously received a programmed cell death receptor-1 (PD-1) or programmed death ligand 1 (PD-L1) inhibitor and a platinum-containing chemotherapy.

PADCEV (Isatuximab) for injection, for intravenous use Initial U.S. Approval: 2019

Generic Name: Isatuximab

For Injection: 20 mg and 30 mg of Isatuximab as a lyophilized powder in a single-dose vial for reconstitution

Isatuximab Price in UK Brazil India

Isatuximab is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Isatuximab suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Isatuximab on prescription and Import License in Patient's Name only.

For overseas patients, Isatuximab can be made available in Send your enquiry to find Isatuximab in U.S., Canada, Mexico, Europe, Germany, France, UK, Italy, Spain, Japan, China, Australia, New Zealand, India, South Korea, Mexico, Argentina, Bolivia, Brazil, Chile, Colombia, Peru, Turkey, Costa Rica, Cuba, Saudi Arabia, South Africa, Ukraine, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

News / Update for Isatuximab.

For Isatuximab Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for PADCEV™ (Isatuximab) in Combination with Pembrolizumab in First-Line Advanced multiple myloma For More Details

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of multiple myloma Patients For More Details